IP Library Granted Patent US 10,337,050
Granted Patent B2
US 10,337,050 · App. 15/427,664 · Granted Jul 2, 2019

Polyphenolic additives in sequencing by synthesis

Inventors: Jerzy Olejnik (Brookline, MA); Michel Georges Perbost (Belmont, MA)
Assignee: Qiagen Sciences, LLC
C12Q1/6823C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,337,050
App. No.
15/427,664
Granted
Jul 2, 2019
Kind
B2
Abstract

The invention relates to methods, compositions, devices, systems and kits as described including, without limitation, reagents and mixtures for determining the identity of nucleic acids in nucleotide sequences using, for example, sequencing by synthesis methods. In particular, the present invention contemplates the use of polyphenolic compounds, known as antioxidant additives, to improve the efficiency of Sequencing-By-Synthesis reactions. For example, gallic acid (GA) is shown herein to be one of many exemplary SBS polyphenolic additives.

Claims (20)

1. A method of incorporating labeled nucleotides, comprising:

a) providing

i) a plurality of nucleic acid primers and template molecules,

ii) a polymerase,

iii) a cleave reagent comprising a reducing agent and the polyphenolic compound gallic acid, and

iv) a plurality of nucleotide analogues wherein at least a portion of said nucleotide analogues is labeled with a label attached through a cleavable disulfide linker to the base;

b) hybridizing at least a portion of said primers to at least a portion of said template molecules so as to create hybridized primers;

c) incorporating a first labeled nucleotide analogue with said polymerase into at least a portion of said hybridized primers so as to create extended primers comprising an incorporated labeled nucleotide analogue;

d) detecting said incorporated labeled nucleotide analogue; and

e) cleaving the cleavable linker of said incorporated nucleotide analogues with said cleave reagent.

2. The method of claim 1 , wherein said reducing agent of said cleave reagent comprises TCEP (tris(2-carboxyethyl)phosphine).

3. The method of claim 1 , wherein said incorporated nucleotide analogues of step c) further comprise a removable chemical moiety capping the 3′-OH group.

4. The method of claim 2 , wherein the cleaving of step e) removes the removable chemical moiety capping the 3′-OH group.

5. The method of claim 4 , wherein the method further comprises:

f) incorporating a second nucleotide analogue with said polymerase into at least a portion of said extended primers.

6. The method of claim 1 , wherein said label is fluorescent.

7. A kit, comprising i) a cleave reagent comprising i) a reducing agent, ii) a polyphenolic compound selected from the group consisting of gallic acid, gentisic acid, pryocatechol, and pyrogallol and iii) a plurality of nucleotide analogues wherein at least a portion of said nucleotide analogues is labeled with a label attached through a cleavable disulfide linker to the base.

8. A system comprising primers hybridized to template in solution, said solution comprising a cleave reagent comprising i) a reducing agent, and ii) a polyphenolic compound selected from the group consisting of gallic acid, gentisic acid, pryocatechol, and pyrogallol.

9. The system of claim 8 , wherein said hybridized primers and template are immobilized.

10. The system of claim 8 , wherein said hybridized primers and template are in a flow cell.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ISOPLEXIS CORPORATION
Reel/Frame 063235/0942 →
PATENT PURCHASE AGREEMENT Recorded Jul 30, 2021
From: QIAGEN SCIENCES, LLC
To: ISOPLEXIS CORPORATION
Reel/Frame 057043/0629 →
SECURITY AGREEMENT Recorded May 28, 2021
From: ISOPLEXIS CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056421/0929 →
MERGER Recorded Nov 8, 2018
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES, LLC
Reel/Frame 047923/0815 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2018
From: OLEJNIK, JERZY; PERBOST, MICHEL GEORGES
To: QIAGEN WALTHAM, INC.
Reel/Frame 045781/0563 →
Continuity (3)
Provisional Application 62419685 · Nov 9, 2016
Provisional Application 62293969 · Feb 11, 2016
Related Publication 20170233796A1 · Aug 17, 2017